Financial Performance

Fintech firm Hometap is betting its new pricing can make home equity investments a true rival to HELOCs, ditching monthly payments for a share of future value.

A new partnership moves AI decisioning to the supply layer, promising advertisers better ROI and a privacy-first path in a world without cookies.

O.C. Tanner's new report reveals 'generational synergy' as a key driver for innovation, offering a crucial playbook for firms navigating AI's rise.

Beyond the grid, Boot Hill Solar is a story of pension fund investment, local economics, and a strategic shift in America's energy heartland. Here's why it matters.

With the EU's Cyber Resilience Act's 24-hour reporting deadline looming, a new class of AI-powered platforms is emerging to manage this unprecedented compliance risk.

As viewers cut the cord, recruiters are following them to streaming platforms. HireClix's new CTV solution signals a major shift in employer branding.

Novara's Form Agent automates EHS paperwork, signaling a larger strategic shift towards AI-driven operational risk management across the industry.

As autonomous AI agents begin managing trillions in commerce, a new identity crisis is brewing. We explore the critical need for governance and the tech aiming to solve it.

A look at how a Massachusetts ABA provider turns clinical assessments into a viable business blueprint, using expert insights and innovative media to scale trust.

California homeowners face a new hurdle: insurers are requiring automatic water shut-off devices to combat costly leaks, reshaping risk in a post-wildfire era.

A new wave of investment aims to shield America's industrial backbone from cyber threats, bringing modern software discipline to the factory floor.

Quoin Pharma's new data for a rare skin disease shows life-changing results in children, offering hope for families. What do the numbers really mean?

With patient dosing underway for its fibroblast-based DFU therapy, FibroBiologics is testing a new paradigm: healing chronic wounds from within.

With its new stablecoin reserve fund, State Street isn't just launching a product. It's forging a regulated path where traditional finance and digital currency finally meet.

In a strategic pivot, GeneDx brings in former Quest and Thermo Fisher exec Mark Gardner to translate its genomic leadership into commercial dominance.

A $25M deal is funding a luxury manufacturer's expansion, revealing a larger story about shifting supply chains and the global appetite for affordable luxury.

Eli Lilly's strategic buyout of a Texas biotech isn't just a deal; it's a bet on a new scientific paradigm to solve the chronic pain crisis without opioids.

A new partnership highlights how regulatory pressure and data analytics are forcing skilled nursing facilities to adopt tech for safer, more efficient patient care.

Amid soaring costs and licensing chaos from market incumbents, Opti9's exclusive deal to distribute Virtuozzo offers a critical lifeline to North American firms.

A small tech firm's entry into the Russell Microcap Index is more than a milestone; it’s a test case for the financial world's appetite for decentralized AI.